Neurogene Inc. (NGNE) vs YD Bio Limited (YDES)

Neurogene Inc. NGNE 23.27 −2.84%
YD Bio Limited YDES 5.92 −12.17%

Neurogene Inc. and YD Bio Limited are both Biotechnology companies. Neurogene Inc. and YD Bio Limited are of similar size ($479.3M and $477.5M).

Metric	NGNE	YDES	Biotechnology median
P/E	n/m	—	8.50
P/S	n/m	—	9.71
P/B	2.42	—	2.13
Price to free cash flow	n/m	—	20.82
EV/EBITDA	n/m	—	0.64
EV/Sales	n/m	—	9.21
Earnings yield	(21.62%)	—	(33.15%)
Free cash flow yield	(16.71%)	—	(25.50%)

Metric	NGNE	YDES	Biotechnology median
Gross margin	0.00%	—	65.16%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(45.32%)	—	(56.36%)
Return on assets	(41.02%)	—	(48.04%)
Return on invested capital	0.00%	—	0.00%

Metric	NGNE	YDES	Biotechnology median
Revenue growth (TTM)	—	—	6.02%
EPS growth (last fiscal year)	0.93%	—	30.26%
Revenue growth, 5-year CAGR	—	—	9.41%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	NGNE	YDES	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	10.64	—	4.72
Net debt to EBITDA	2.57	—	0.96

Metric	NGNE	YDES	Biotechnology median
Dividend yield	—	—	0.09%
Payout ratio	—	—	—

Metric	NGNE	YDES	Biotechnology median
Market cap	479.27m	477.48m	135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack